Intuitive Capital Surpluse vs Deferred Long Term Liab Analysis
ISRG Stock | USD 381.36 0.00 0.00% |
Intuitive Surgical financial indicator trend analysis is infinitely more than just investigating Intuitive Surgical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Intuitive Surgical is a good investment. Please check the relationship between Intuitive Surgical Capital Surpluse and its Deferred Long Term Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.
Capital Surpluse vs Deferred Long Term Liab
Capital Surpluse vs Deferred Long Term Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Intuitive Surgical Capital Surpluse account and Deferred Long Term Liab. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Intuitive Surgical's Capital Surpluse and Deferred Long Term Liab is 0.85. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Intuitive Surgical, assuming nothing else is changed. The correlation between historical values of Intuitive Surgical's Capital Surpluse and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of Intuitive Surgical are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Capital Surpluse i.e., Intuitive Surgical's Capital Surpluse and Deferred Long Term Liab go up and down completely randomly.
Correlation Coefficient | 0.85 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Capital Surpluse
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Most indicators from Intuitive Surgical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Intuitive Surgical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.The Intuitive Surgical's current Selling General Administrative is estimated to increase to about 2.1 B. The Intuitive Surgical's current Tax Provision is estimated to increase to about 162.9 M
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 310.2M | 365.8M | 421.8M | 442.9M | Income Tax Expense | 162.2M | 262.4M | 141.6M | 137.0M |
Intuitive Surgical fundamental ratios Correlations
Click cells to compare fundamentals
Intuitive Surgical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Intuitive Surgical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.7B | 11.2B | 13.6B | 13.0B | 15.4B | 16.2B | |
Total Stockholder Equity | 8.3B | 9.8B | 12.0B | 11.1B | 13.3B | 14.0B | |
Net Debt | (1.1B) | (1.5B) | (1.2B) | (1.5B) | (2.7B) | (2.5B) | |
Retained Earnings | 2.5B | 3.3B | 4.8B | 3.5B | 4.7B | 5.0B | |
Common Stock Shares Outstanding | 358.5M | 360.9M | 365.8M | 362M | 357.4M | 333.9M | |
Liabilities And Stockholders Equity | 9.7B | 11.2B | 13.6B | 13.0B | 15.4B | 16.2B | |
Non Current Liabilities Total | 159.7M | 139M | 224.1M | 439.3M | 385.5M | 404.8M | |
Other Stockholder Equity | 5.8B | 6.5B | 7.2B | 7.8B | 8.6B | 9.0B | |
Total Liab | 1.4B | 1.4B | 1.6B | 1.9B | 2.0B | 2.1B | |
Other Current Liab | 568.9M | 923.9M | 1.0B | 1.3B | 998.6M | 1.0B | |
Total Current Liabilities | 1.4B | 1.4B | 1.6B | 1.9B | 1.7B | 1.7B | |
Property Plant And Equipment Net | 1.3B | 1.6B | 1.9B | 2.4B | 3.5B | 3.7B | |
Accounts Payable | 1.1B | 81.6M | 121.2M | 147M | 188.7M | 101.8M | |
Cash | 1.2B | 1.6B | 1.3B | 1.6B | 2.8B | 1.6B | |
Non Current Assets Total | 2.2B | 3.1B | 3.6B | 4.4B | 7.6B | 7.9B | |
Cash And Short Term Investments | 5.8B | 6.9B | 8.6B | 6.7B | 5.2B | 2.8B | |
Net Receivables | 645.2M | 645.5M | 782.7M | 942.1M | 1.3B | 1.3B | |
Short Term Investments | 2.1B | 3.5B | 2.9B | 2.5B | 2.5B | 2.6B | |
Inventory | 595.5M | 601.5M | 587.1M | 893.2M | 1.2B | 1.3B | |
Other Current Assets | 200.2M | 267.5M | 271.1M | 164.3M | 176.7M | 185.5M | |
Total Current Assets | 7.5B | 8.1B | 10.0B | 8.6B | 7.9B | 8.3B | |
Accumulated Other Comprehensive Income | 12.4M | 24.9M | (24.2M) | (162.5M) | (12.2M) | (12.8M) | |
Short Term Debt | (568.9M) | 21.9M | 20.4M | 24.2M | 25.3M | 22.9M | |
Non Currrent Assets Other | (2.4B) | (986.6M) | (3.5B) | (1.6B) | 597.6M | 627.5M | |
Property Plant And Equipment Gross | 1.3B | 1.6B | 2.8B | 3.6B | 5.1B | 5.4B | |
Intangible Assets | 112.1M | 77.4M | 70.5M | 49.8M | 636.7M | 668.5M | |
Property Plant Equipment | 1.3B | 1.6B | 1.9B | 2.4B | 2.7B | 2.9B | |
Current Deferred Revenue | 365.2M | 382.4M | 414M | 438.3M | 446.1M | 468.4M | |
Other Liab | 349.6M | 386.6M | 414M | 369.7M | 425.2M | 446.4M | |
Other Assets | 680.5M | 2.1B | 13.6B | 1.2B | 1.4B | 1.1B | |
Good Will | 307.2M | 336.7M | 343.6M | 348.5M | 348.7M | 214.6M | |
Net Tangible Assets | 7.5B | 8.9B | 11.6B | 10.0B | 11.5B | 5.9B | |
Noncontrolling Interest In Consolidated Entity | 20.9M | 27.6M | 50.4M | 70.7M | 81.3M | 85.4M | |
Retained Earnings Total Equity | 2.5B | 3.3B | 4.8B | 3.5B | 4.0B | 4.2B | |
Capital Surpluse | 5.8B | 6.4B | 7.2B | 7.7B | 8.9B | 4.6B | |
Deferred Long Term Liab | 51.5M | 53.1M | 71.8M | 72.3M | 83.1M | 87.3M | |
Long Term Investments | 2.6B | 1.8B | 4.4B | 2.6B | 2.1B | 2.1B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Intuitive Stock analysis
When running Intuitive Surgical's price analysis, check to measure Intuitive Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intuitive Surgical is operating at the current time. Most of Intuitive Surgical's value examination focuses on studying past and present price action to predict the probability of Intuitive Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intuitive Surgical's price. Additionally, you may evaluate how the addition of Intuitive Surgical to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Intuitive Surgical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intuitive Surgical. If investors know Intuitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intuitive Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.51 | Earnings Share 5.55 | Revenue Per Share 20.79 | Quarterly Revenue Growth 0.115 | Return On Assets 0.08 |
The market value of Intuitive Surgical is measured differently than its book value, which is the value of Intuitive that is recorded on the company's balance sheet. Investors also form their own opinion of Intuitive Surgical's value that differs from its market value or its book value, called intrinsic value, which is Intuitive Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intuitive Surgical's market value can be influenced by many factors that don't directly affect Intuitive Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intuitive Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intuitive Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intuitive Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.